Who We Are

IPI is a vertically integrated leader in the global medical cannabis market. Holding one of the first Caribbean cultivation, extraction and exportation licences, IPI is an extraction and consumer processed goods focused company that manufactures luxury CBD and medical cannabis products. We are globally connected with international distribution capabilities; focused on value creation. Our extracts are EU-GMP certified produced in a world-class extraction facility.

We have a key understanding of market access and in-depth knowledge of country-specific regulatory pathways.

IPI is led by a strategic and experienced management team. CEO, Angus Taylor, founded and sold Canada’s largest retail cannabis chain, NewLeaf Cannabis.

Our products are created with the idea of bringing low-cost, high-quality cannabis to the medical and therapeutic markets to enhance health and wellness globally. IPI has strategic partnerships to ensure we are compliant, consistent and credible producer.


Located in a key strategic position of Saint Vincent and the Grenadines

The location will provide us the ability to grow, process, sell and export low-cost, EU-GMP certified cannabis ingredients for use in medicinal and therapeutic markets. This will lay the foundation for a comprehensive ‘seed to sale’ business model.

The company’s focus is to develop a mutually advantageous partnerships across the country that will create positive benefits for Vincentians. The partnership with the island nation will result in positive social and economic impacts for the people.